|Tel||+44 (0)1865 (2)23423|
Arthritis Research UK Fellow
Dr Sarah Snelling received an MBiochem from the department of Biochemistry, University of Oxford before moving to the Botnar Research Centre to pursue a DPhil in the genetics and functionality of OA.
In 2009 Dr Snelling took up an Arthritis Research UK Foundation Fellowship at the University of East Anglia where she established the role of the Wnt antagonist Dkk3 in osteoarthritis.
In 2012 Dr Snelling returned to the Botnar Research Centre to continue in vivo studies of Dkk3 in OA as an Arthritis Research UK Career Progression Fellow. Within this post she is pursuing her interest in exploiting the inherent repair properties of musculoskeletal tissues through their interaction with scaffolds and inflammatory mediators alongside Professor Andrew Carr's research group.
Dean BJ. et al, (2015), Arthritis Res Ther, 17
Snelling S. et al, (2014), Osteoarthritis Cartilage, 22, 334 - 343
Poulsen RC. et al, (2014), Ann Rheum Dis, 73, 1405 - 1413
Davies BM. et al, (2013), Regen Med, 8, 613 - 630
Snelling SJ. et al, (2010), Growth Factors, 28, 268 - 279
Presence of IL-17 in synovial fluid identifies a potential inflammatory osteoarthritic phenotype
Lubbeke-Wolff� A., (2017), PLoS One
Kendal A. et al, (2017), European Cells and Materials
Mouthuy PA. et al, (2016), Biomaterials, 109, 55 - 68
Morita W. et al, (2016), Arthritis Res Ther, 18
Rowland DC. et al, (2016), J Biomed Mater Res A, 104, 2843 - 2853